Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in Spain.

Conclusions: Health costs of patients with severe asthma were high. Total annual asthma costs and resource use were greater in patients with ≥300 cells/μl. Age, eosinophilia, exacerbations and FEV1 were associated with greater resource utilization and costs for the health system. PMID: 31958257 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31958257?dopt=Abstract

Source: Journal of Medical Economics - January 22, 2020 Category: Health Management Tags: J Med Econ Source Type: research